Yayın:
A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy

Sadeleştirilmiş öğe sayfası
dc.contributor.authorÖZDEMİR, AHMET
dc.contributor.authorSEVER, BELGİN
dc.contributor.authorALTINTOP, MEHLİKA DİLEK
dc.contributor.authorHiroshi Tateishi
dc.contributor.authorMasami Otsuka
dc.contributor.authorMikako Fujita
dc.contributor.authorMehlika Dilek Altıntop
dc.contributor.orcid0000-0003-0280-5550
dc.contributor.orcid0000-0002-9796-7669
dc.contributor.orcid0000-0003-4847-9711
dc.contributor.orcid0000-0003-1225-0720
dc.contributor.orcid0000-0002-2968-3939
dc.contributor.orcid0000-0001-6705-4052
dc.contributor.orcid0000-0002-8159-663X
dc.date.accessioned2025-11-13T10:23:59Z
dc.date.issued2022-01-13
dc.identifier.doihttps://doi.org/10.3390/molecules27020485
dc.identifier.endpage485
dc.identifier.issn1420-3049
dc.identifier.issue2
dc.identifier.openalexW4206485501
dc.identifier.startpage485
dc.identifier.urihttps://hdl.handle.net/11421/4032
dc.identifier.urihttps://doi.org/10.3390/molecules27020485
dc.identifier.volume27
dc.language.isoen
dc.relation.ispartofMolecules
dc.rightsopenAccess
dc.subjectErlotinib
dc.subjectLung cancer
dc.subjectPharmacology
dc.subjectEpidermal growth factor receptor
dc.subjectContext (archaeology)
dc.subjectEGFR inhibitors
dc.subjectTargeted therapy
dc.subjectMedicine
dc.subjectCancer research
dc.subjectCytotoxicity
dc.subjectAdenocarcinoma
dc.subjectIC50
dc.subjectPeripheral blood mononuclear cell
dc.subjectTyrosine kinase
dc.subjectCancer
dc.subjectIn vitro
dc.subjectChemistry
dc.subjectOncology
dc.subjectInternal medicine
dc.subjectBiology
dc.subjectReceptor
dc.subjectBiochemistry
dc.subject.sdg3
dc.titleA New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5100651829
local.authorid.openalexA5040352588
local.authorid.openalexA5048968214

Dosyalar

Koleksiyonlar

Publications